PNQI Stock Recent News Nasdaq Internet Powershares (PNQI) 68.94

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Internet Powershares (PNQI) 68.94 $PNQI

Big Tree Capital And Exchange Traded Concepts team up to launch EMQQ
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 11:20AM CST

ARKW: 20.75 (+0.34), FDN: 62.20 (+0.87), EMQQ: 26.42 (+0.45), PNQI: 68.94 (+0.96)

ETFs in Focus on Amazon Q3 Earnings Miss and Weak Guidance - ETF News And Commentary
Sweta Killa - ZACKS - Mon Oct 27, 12:00PM CDT
Amazon shares tumbled on Q3 earnings miss and weak guidance. Has this created an attractive entry point for investors?
AMZN: 327.82 (+11.34), FDN: 62.20 (+0.87), RTH: 67.34 (+0.06), PNQI: 68.94 (+0.96)

Google's Q3 Earnings Miss Might Be Trouble for These ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 11:00AM CDT
These technology ETFs are in focus following yet another earnings miss from Google.
FDN: 62.20 (+0.87), GOOGL: 555.19 (-1.25), PNQI: 68.94 (+0.96), GOOG: 544.40 (-0.98), IYW: 104.32 (+0.90)

eBay Crumbles on Mixed Q3 and Weak Outlook: 3 ETFs to Watch (revised) - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Oct 16, 11:00AM CDT
eBay stock is down close to 25 percent thanks to a weak outlook, putting these ETFs in focus.
MOAT: 31.86 (+0.03), EBAY: 54.36 (-0.01), FDN: 62.20 (+0.87), PNQI: 68.94 (+0.96)

Netflix Weak Q3 User Growth & Outlook Might Crush These ETFs - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Oct 16, 8:30AM CDT
The sharp fall in Netflix share price following disappointing user growth and outlook could bring some cracks in these ETFs.
PBS: 25.03 (+0.19), NFLX: 386.04 (+6.63), FDN: 62.20 (+0.87), PNQI: 68.94 (+0.96)

Google, Facebook, Amazon, others slide following Netflix/eBay's results
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 3:45PM CDT

SOCL: 19.81 (+0.38), AMZN: 327.82 (+11.34), LNKD: 233.89 (+4.12), FB: 74.88 (+0.63), FDN: 62.20 (+0.87), YELP: 59.82 (+1.72), TWTR: 41.85 (+1.81), PNQI: 68.94 (+0.96), GOOG: 544.40 (-0.98)

PNQI Is A Buy After The Recent Correction
Lior Ronen - Amigobulls - Mon Oct 13, 8:42AM CDT
Recent correction in PNQI has presented investors with a good entry point while upcoming internet IPO's could lead to significant upside in the stock price.
SPY: 204.24 (+0.05), QQQ: 103.22 (+0.32), DIA: 176.35 (-0.09), PNQI: 68.94 (+0.96)

Amazon Posts Wider-than-Expected Loss: 3 ETFs to Watch - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Jul 25, 12:00PM CDT
Investors should closely watch the movement of these ETFs following Amazon weak earnings and sluggish short-term outlook.
FDN: 62.20 (+0.87), RTH: 67.34 (+0.06), PNQI: 68.94 (+0.96)

Facebook Beats but Lofty Valuation Puts These ETFs on Watch - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Jul 24, 12:00PM CDT
Given Facebook impressive results but valuation concerns, investors should closely watch ETFs with larger allocation to this networking giant.
SOCL: 19.81 (+0.38), FPX: 49.18 (+0.32), FB: 74.88 (+0.63), PNQI: 68.94 (+0.96)

2 ETFs to Ride on Netflix Q2 Strength - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jul 22, 12:00PM CDT
Netflix topped estimates with strong growth potential and expansion plans. Investors could ride this strength in the form of ETFs.
NFLX: 386.04 (+6.63), FDN: 62.20 (+0.87), PNQI: 68.94 (+0.96)

Mixed Earnings from Google and Yahoo Put Internet ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 11:00AM CDT
Watch these internet ETFs following the mixed results from Google and Yahoo.
YHOO: 51.75 (+1.25), GOOGL: 555.19 (-1.25), FDN: 62.20 (+0.87), GOOG: 544.40 (-0.98), PNQI: 68.94 (+0.96)

ETFs to Buy on Netflix Rise Following Goldman Upgrade - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 9:00AM CDT
Netflix shares surged after the Goldman upgrade, putting these two ETFs in focus.
NFLX: 386.04 (+6.63), AMZN: 327.82 (+11.34), FDN: 62.20 (+0.87), PNQI: 68.94 (+0.96), PCLN: 1,172.96 (+4.95)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Current Market Sentiment on HealthEquity Shares: A Closer Look

Updated Category News Views 113

Understanding HealthEquity's Short Interest Dynamics HealthEquity Inc (NYSE: HQY) has seen a significant decrease in its short percent of float, which recently dropped by 11.68%. As of the last report, the company had approximately 5.26 million shares sold short, representing 7.03% of its regular shares available for trading. This situation also highlights an average...

Continue Reading
Investors Update: Class Action Against Bumble Inc. Soon

Updated Category News Views 104

Update on Class Action Lawsuit Against Bumble Inc. (BMBL) The Law Offices of Frank R. Cruz are reminding investors about an upcoming significant deadline concerning a class action lawsuit against Bumble Inc. This lawsuit affects investors who acquired BMBL securities during the designated Class Period. Understanding the Class Action Lawsuit The class action was initiated...

Continue Reading
Analysis of Williams-Sonoma's Recent Surge and Current Changes

Updated Category News Views 293

Understanding Williams-Sonoma's Recent Stock Movements This week has seen an impressive rise of nearly 30% in shares of Williams-Sonoma, Inc. (NYSE: WSM), but recent trading indicates a slight pullback. Investors are reacting to two key factors: the natural tendency to take profits and the decision of some buyers to exit losing positions as market conditions evolve. The...

Continue Reading
Understanding the Arconic Corporation Class Action Update

Updated Category News Views 139

Overview of the Class Action Lawsuit Against Arconic Corporation Levi & Korsinsky, LLP has recently announced a class action regarding Arconic Corporation (ARNC). This situation affects investors who may have been impacted by alleged securities fraud. The firm aims to represent those who traded Arconic shares during a specified period and seeks to recover losses resulting...

Continue Reading
Cambrex Partners with Lilly to Enhance Biotech Innovations

Updated Category News Views 220

Cambrex's Strategic Collaboration with Eli Lilly Cambrex, a key player in the global contract development and manufacturing organization (CDMO) sector, has announced an exciting new partnership with Eli Lilly and Company to enhance support for biotech collaborators. Through this agreement, Cambrex aims to provide accelerated access to essential clinical development...

Continue Reading